Soleno Therapeutics (SLNO) has had the highest return since May 31, 2022 by a US stock with a market cap of $2B to $10B or a market cap of $200B+, returning 1,738.9%.
| ASSET | % RETURN |
|---|---|
Soleno Therapeutics (SLNO) | 1,738.92% |
Rhythm Pharmaceuticals (RYTM) | 1,700% |
Viking Therapeutics (VKTX) | 1,325.53% |
Verona Pharma PLC ADR (VRNA) | 1,263.78% |
Palantir Technologies Inc Class A Common Stock (PLTR) | 1,029.99% |
Hims Hers Health (HIMS) | 934.31% |
Powell Industries (POWL) | 875.7% |
Nuvalent (NUVL) | 849.41% |
Modine Manufacturing (MOD) | 837.91% |
BBVA Banco Frances SA ADR (BBAR) | 811.89% |
Scholar Rock (SRRK) | 756.65% |
ADMA Biologics (ADMA) | 726.96% |
Banco Macro SA B ADR (BMA) | 641.85% |
IES (IESC) | 624% |
IONQ (IONQ) | 600.66% |
NVIDIA (NVDA) | 558.62% |
TG Therapeutics (TGTX) | 556.83% |
Akero Therapeutics (AKRO) | 555.58% |
Biohaven Pharmaceutical (BHVN) | 552.33% |
Brinker International (EAT) | 523.59% |
MoonLake Immunotherapeutics (MLTX) | 517.62% |
Arcellx (ACLX) | 483.99% |
Sterling Construction (STRL) | 482.07% |
Carpenter Technology (CRS) | 455.95% |
Immunovant (IMVT) | 443.72% |
